Division of Radiotherapy and Imaging
John R. Yarnold has not added Biography.
If you are John R. Yarnold and would like to personalize this page please email our Author Liaison for assistance.
Magnetic resonance imaging of induration in the irradiated breast.
Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology Aug, 2002 | Pubmed ID: 12242125
Sequential or concurrent tamoxifen and radiotherapy: to see or not to see--that is the question!
Journal of clinical oncology : official journal of the American Society of Clinical Oncology Sep, 2005 | Pubmed ID: 16135499
Effect of radiotherapy fraction size on tumour control in patients with early-stage breast cancer after local tumour excision: long-term results of a randomised trial.
The lancet oncology Jun, 2006 | Pubmed ID: 16750496
Local relapse rates are falling after breast conserving surgery and systemic therapy for early breast cancer: can radiotherapy ever be safely withheld?
Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology Jan, 2009 | Pubmed ID: 18502528
Postmastectomy radiotherapy: will the selective use of postmastectomy radiotherapy study end the debate?
Journal of clinical oncology : official journal of the American Society of Clinical Oncology Feb, 2009 | Pubmed ID: 19164209
Characterization of target volume changes during breast radiotherapy using implanted fiducial markers and portal imaging.
International journal of radiation oncology, biology, physics Mar, 2009 | Pubmed ID: 19215828
Shorter fractionation schedules in breast cancer radiotherapy: clinical and economic implications.
European journal of cancer (Oxford, England : 1990) Mar, 2009 | Pubmed ID: 19243933
Tumor bed delineation for partial breast and breast boost radiotherapy planned in the prone position: what does MRI add to X-ray CT localization of titanium clips placed in the excision cavity wall?
International journal of radiation oncology, biology, physics Jul, 2009 | Pubmed ID: 19464816
Genome-wide transcriptomic profiling of microdissected human breast tissue reveals differential expression of KIT (c-Kit, CD117) and oestrogen receptor-alpha (ERalpha) in response to therapeutic radiation.
The Journal of pathology Sep, 2009 | Pubmed ID: 19562735
How does knowledge of three-dimensional excision margins following breast conservation surgery impact upon clinical target volume definition for partial-breast radiotherapy?
Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology Mar, 2010 | Pubmed ID: 19963294
Target volume definition for external beam partial breast radiotherapy: clinical, pathological and technical studies informing current approaches.
Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology Mar, 2010 | Pubmed ID: 20080310
Comparison of patient-reported breast, arm, and shoulder symptoms and body image after radiotherapy for early breast cancer: 5-year follow-up in the randomised Standardisation of Breast Radiotherapy (START) trials.
The lancet oncology Mar, 2010 | Pubmed ID: 20138809
Hypofractionated radiotherapy for breast cancer.
The New England journal of medicine May, 2010 | Pubmed ID: 20463347
Ipsilateral breast tumor relapse: local recurrence versus new primary tumor and the effect of whole-breast radiotherapy on the rate of new primaries.
International journal of radiation oncology, biology, physics Jan, 2011 | Pubmed ID: 20471183
Prone versus supine positioning for whole and partial-breast radiotherapy: a comparison of non-target tissue dosimetry.
Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology Aug, 2010 | Pubmed ID: 20561695
Reports of unexpected late side effects of accelerated partial breast irradiation--radiobiological considerations.
International journal of radiation oncology, biology, physics Jul, 2010 | Pubmed ID: 20610037
A randomised trial of supine versus prone breast radiotherapy (SuPr study): comparing set-up errors and respiratory motion.
Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology Aug, 2011 | Pubmed ID: 21159397
Gene expression profiling of human dermal fibroblasts exposed to bleomycin sulphate does not differentiate between radiation sensitive and control patients.
Radiation oncology (London, England) , 2011 | Pubmed ID: 21521514
First results of the randomised UK FAST Trial of radiotherapy hypofractionation for treatment of early breast cancer (CRUKE/04/015).
Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology Jul, 2011 | Pubmed ID: 21752481
Ductal carcinoma in situ of the breast.
BMJ (Clinical research ed.) , 2012 | Pubmed ID: 22378935
Conducting radiogenomic research--do not forget careful consideration of the clinical data.
Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology Dec, 2012 | Pubmed ID: 23245646
The UK HeartSpare Study: randomised evaluation of voluntary deep-inspiratory breath-hold in women undergoing breast radiotherapy.
Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology Aug, 2013 | Pubmed ID: 23726115
The UK Standardisation of Breast Radiotherapy (START) trials of radiotherapy hypofractionation for treatment of early breast cancer: 10-year follow-up results of two randomised controlled trials.
The lancet oncology Oct, 2013 | Pubmed ID: 24055415
Changes in mast cell number and stem cell factor expression in human skin after radiotherapy for breast cancer.
Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology May, 2014 | Pubmed ID: 24746564
Late effects of breast radiotherapy.
Lancet Apr, 2014 | Pubmed ID: 24759249
Cytokine levels as biomarkers of radiation fibrosis in patients treated with breast radiotherapy.
Radiation oncology (London, England) , 2014 | Pubmed ID: 24885397
Frederick R. Bartlett1,
Ruth M. Colgan1,
Ellen M. Donovan1,
Karen Carr1,
Steven Landeg1,
Nicola Clements1,
Helen A. McNair1,
Imogen Locke1,
Philip M. Evans2,
Joanne S. Haviland3,
John R. Yarnold4,
Anna M. Kirby1
1Department of Radiotherapy, Royal Marsden NHS Foundation Trust,
2Centre for Vision, Speech and Signal Processing, Faculty of Engineering and Physical Sciences, University of Surrey,
3Clinical Trials and Statistics Unit (ICR-CTSU), Institute of Cancer Research, Sutton, UK,
4Division of Radiotherapy and Imaging, Institute of Cancer Research, Sutton, UK
ACERCA DE JoVE
Copyright © 2024 MyJoVE Corporation. Todos los derechos reservados